著者: NofalEman, EmamShimaa, AldesokyFatma, GhonemySoheir, AdelshafyAhmad

原題: Intralesional bivalent human papilloma virus vaccine as a treatment for anogenital warts versus topical podophyllin resin 25%: A pilot study.

著者: GilcaVladimir, SauvageauChantal, BoulianneNicole, De SerresGatson, CrajdenMel, OuakkiManale, TrevisanAndrea, DionneMarc

原題: The effect of a booster dose of quadrivalent or bivalent HPV vaccine when administered to girls previously vaccinated with two doses of quadrivalent HPV vaccine.

著者: PoppeW A, SimonP H, De RidderM R

原題: Why consider human papillomavirus vaccination in older women?

著者:

原題: FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP).

著者: Lyseng-WilliamsonKatherine A

原題: Human papillomavirus-16/18 AS04-adjuvanted vaccine (cervarix®): a guide to its two-dose schedule in girls aged 9-14 years in the EU.

著者: GermarMaria Julieta, PuruggananCarrie, BernardinoMa Socorro, CuencaBenjamin, ChenY-Chen, LiXiao, Van KriekingeGeorges, LeeI-Heng

原題: Cost-effectiveness analysis of AS04-adjuvanted human papillomavirus 16/18 vaccine compared with human papillomavirus 6/11/16/18 vaccine in the Philippines, with the new 2-dose schedule.

著者: EspositoSusanna, BirlutiuVictoria, JarcuskaPavol, PerinoAntonio, ManSorin Claudiu, VladareanuRadu, MericDorothée, DobbelaereKurt, ThomasFlorence, DescampsDominique

原題: Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted vaccine administered according to an alternative dosing schedule compared with the standard dosing schedule in healthy women aged 15 to 25 years: results from a randomized study.

著者: LeungTing Fan, LiuAnthony Pak-Yin, LimFong Seng, ThollotFranck, OhHelen May Lin, LeeBee Wah, RomboLars, TanNgiap Chuan, RouzierRoman, FrielDamien, De MuynckBenoit, De SimoniStéphanie, SuryakiranPemmaraju, HezarehMarjan, FolschweillerNicolas, ThomasFlorence, StruyfFrank

原題: Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine administered according to 2- and 3-dose schedules in girls aged 9-14 years: Results to month 12 from a randomized trial.

著者: SchwarzTino F, HuangLi-Min, LinTzou-Yien, WittermannChristoph, PanzerFalko, ValenciaAlejandra, SuryakiranPemmaraju V, LinLan, DescampsDominique

原題: Long-term immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in 10- to 14-year-old girls: open 6-year follow-up of an initial observer-blinded, randomized trial.

著者: SchwarzTino F, HuangLi-Min, ValenciaAlejandra, PanzerFalko, ChiuCheng-Hsun, DecreuxAnnabelle, PonceletSylviane, KarkadaNaveen, FolschweillerNicolas, LinLan, DubinGary, StruyfFrank

原題: A ten-year study of immunogenicity and safety of the AS04-HPV-16/18 vaccine in adolescent girls aged 10-14 years.

著者: DengSiwei, WelbySarah, LiuZhike, YangYu, MengRuogu, SunYixin, YangJunting, LiuGuangxu, HeYunkun, JiangNing, WuZhenhua, LiuKeruo, RosillonDominique, CohetCatherine, BorysDorota, ZhanSiyan

原題: MOnitoring human papillomavirus Vaccine effect on Infection and cErvical diseases (MOVIE): Protocol for a cohort study using electronic health records from Yinzhou, China.

著者: RomanowskiBarbara, SchwarzTino F, FergusonLinda M, PetersKlaus, DionneMarc, SchulzeKarin, RamjattanBrian, HillemannsPeter, CatteauGrégory, DobbelaereKurt, SchuindAnne, DescampsDominique

原題: Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared with the licensed 3-dose schedule: results from a randomized study.